Serum Anti-Amyloid-β Antibodies and Alzheimer's Disease in Elderly Korean Patients

Author： Song MS Mook-Jung I Lee HJ Min JY Park MH

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.35, Iss.3, 2007-05, pp. : 301-306

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of Amyloid-&bgr; Aggregation in Alzheimer's Disease

Current Pharmaceutical Design, Vol. 20, Iss. 8, 2014-03 ,pp. : 1223-1243

Bentham Science Publishers

Access to resources Recommend Favorite

Disrupting &bgr;-Amyloid Aggregation for Alzheimer Disease Treatment

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 1, 2007-01 ,pp. : 115-126

Bentham Science Publishers

Access to resources Recommend Favorite

Measurement of Anti-TNF Agents and Anti-Drug Antibodies Serum Levels in Patients with Inflammatory Bowel Disease

Current Drug Metabolism, Vol. 15, Iss. 9, 2014-11 ,pp. : 875-881

Bentham Science Publishers

Access to resources Recommend Favorite

β-Amyloid peptide as a target for treatment of Alzheimer’s disease

By Conde Santiago

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 4, 2002-04 ,pp. : 503-512

Informa Healthcare

Access to resources Recommend Favorite

Commentary Research Highlights (Amyloid &bgr;-Peptide and Alzheimer's Disease: It's All the RAGE)

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 5, 2012-08 ,pp. : 494-494

Bentham Science Publishers

Access to resources Recommend Favorite